Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,289 papers from all fields of science
Search
Sign In
Create Free Account
Corrected serum calcium measurement
Known as:
Corrected Serum Calcium
An estimate of serum calcium, corrected for the amount of albumin-bound calcium, used when albumin levels are not within normal ranges. It uses the…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism
P. Riss
,
M. Kammer
,
+4 authors
B. Niederle
Clinical Endocrinology
2016
Corpus ID: 22649693
The effects of thiazide medication in patients with primary hyperparathyroidism (PHPT) have so far not been elucidated. The aim…
Expand
2013
2013
Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era?
N. Shinohara
,
T. Abe
,
+6 authors
K. Nonomura
Urologic oncology
2013
Corpus ID: 668707
2012
2012
Association Between Nondipper Behavior and Serum Calcium in Hypertensive Patients with Mild-to-Moderate Chronic Renal Dysfunction
C. Feldstein
,
M. Akopian
,
A. Olivieri
,
D. Garrido
Clinical and experimental hypertension
2012
Corpus ID: 207516254
A nondipping BP pattern has been shown to be predictive of end-organ damage, cardiovascular events, and mortality. The mechanisms…
Expand
Review
2012
Review
2012
Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site: a 10-year cohort study
Kuo-Wei Chen
,
Chia-Jen Liu
,
+11 authors
Muh-Hwa Yang
BMC Research Notes
2012
Corpus ID: 7674767
Carcinoma of unknown primary site (CUP) has a poor prognosis and the prognostic factors in these patients are not well…
Expand
2010
2010
Identification of a second kindred with familial hypocalciuric hypercalcemia type 3 (FHH3) narrows localization to a <3.5 megabase pair region on chromosome 19q13.3.
M. Nesbit
,
F. Hannan
,
+4 authors
R. Thakker
Journal of Clinical Endocrinology and Metabolism
2010
Corpus ID: 207080274
CONTEXT Familial hypocalciuric hypercalcemia (FHH) is a genetically heterogenous disorder that consists of three defined types…
Expand
2008
2008
Mineral Metabolism in Obese Patients Following Vertical Banded Gastroplasty
J. Olmos
,
L. Vázquez
,
J. Amado
,
J. Hernández
,
J. González Macías
Obesity Surgery
2008
Corpus ID: 23532717
BackgroundBone disease has been described in patients after surgical treatment for obesity, but few studies have dealt with the…
Expand
2005
2005
A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
K. Kawada
,
H. Minami
,
+6 authors
S. Takashima
Japanese Journal of Clinical Oncology
2005
Corpus ID: 25647920
BACKGROUND Hypercalcemia of malignancy is a serious complication of cancer. The objective of this study was to investigate the…
Expand
2001
2001
Higher expression of K‐ras is associated with parathyroid hormone‐related protein‐induced hypercalcaemia in renal cell carcinoma
T. Kamai
,
K. Arai
,
+6 authors
K.‐I. Yoshida
BJU International
2001
Corpus ID: 29873625
Objectives To determine whether the K‐ras oncogene is associated with parathyroid hormone‐related protein (PTHrP) production in…
Expand
Review
2001
Review
2001
Zoledronic acid: an evolving role in the treatment of cancer patients with bone disease.
H. Fleisch
Seminars in Oncology
2001
Corpus ID: 42380375
1989
1989
Comparison of different dose regimes of aminohydroxypropylidene-1,1-bisphosphonate (APD) in hypercalcaemia of malignancy.
J. Davis
,
D. Heath
British Journal of Clinical Pharmacology
1989
Corpus ID: 24012618
1. The new intravenous bisphosphonate drug aminohydroxypropylidine bisphosphonate (APD) is effective in treating the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE